In September 2023 GHK-Cu, also known as copper peptide or glycyl-l-histidyl-l-lysine copper complex, was added to the 503A bulks list in category 1
Post-Injection Care Discard the remainder: the vial is single-dose and preservative-free the leftover is not a next-day dose, and the label caps use of the reconstituted solution at 3 hours [1]
The potential for discovery in peptide research is immense, but it all begins with getting the fundamentals right
Reported side effects in available research and clinical use include fatigue, headaches, nausea, and injection site irritation generally mild, but again, incompletely characterized over long-term use
At The Face Clinic, IV infusions are positioned as supportive interventions, not disease treatments
J Chem Phys 79:926935